Global Female Contraceptives Market Research Report 2023

Report ID: 1991502 | Published Date: Oct 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Female Contraceptives Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Contraceptive Drugs
        1.2.3 Contraceptive Devices
    1.3 Market by Application
        1.3.1 Global Female Contraceptives Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Personal use
        1.3.3 Hospital
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Female Contraceptives Market Perspective (2017-2028)
    2.2 Female Contraceptives Growth Trends by Region
        2.2.1 Female Contraceptives Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Female Contraceptives Historic Market Size by Region (2017-2022)
        2.2.3 Female Contraceptives Forecasted Market Size by Region (2023-2028)
    2.3 Female Contraceptives Market Dynamics
        2.3.1 Female Contraceptives Industry Trends
        2.3.2 Female Contraceptives Market Drivers
        2.3.3 Female Contraceptives Market Challenges
        2.3.4 Female Contraceptives Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Female Contraceptives Players by Revenue
        3.1.1 Global Top Female Contraceptives Players by Revenue (2017-2022)
        3.1.2 Global Female Contraceptives Revenue Market Share by Players (2017-2022)
    3.2 Global Female Contraceptives Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Female Contraceptives Revenue
    3.4 Global Female Contraceptives Market Concentration Ratio
        3.4.1 Global Female Contraceptives Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Female Contraceptives Revenue in 2021
    3.5 Female Contraceptives Key Players Head office and Area Served
    3.6 Key Players Female Contraceptives Product Solution and Service
    3.7 Date of Enter into Female Contraceptives Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Female Contraceptives Breakdown Data by Type
    4.1 Global Female Contraceptives Historic Market Size by Type (2017-2022)
    4.2 Global Female Contraceptives Forecasted Market Size by Type (2023-2028)
5 Female Contraceptives Breakdown Data by Application
    5.1 Global Female Contraceptives Historic Market Size by Application (2017-2022)
    5.2 Global Female Contraceptives Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Female Contraceptives Market Size (2017-2028)
    6.2 North America Female Contraceptives Market Size by Country (2017-2022)
    6.3 North America Female Contraceptives Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Female Contraceptives Market Size (2017-2028)
    7.2 Europe Female Contraceptives Market Size by Country (2017-2022)
    7.3 Europe Female Contraceptives Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Female Contraceptives Market Size (2017-2028)
    8.2 Asia-Pacific Female Contraceptives Market Size by Country (2017-2022)
    8.3 Asia-Pacific Female Contraceptives Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Female Contraceptives Market Size (2017-2028)
    9.2 Latin America Female Contraceptives Market Size by Country (2017-2022)
    9.3 Latin America Female Contraceptives Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Female Contraceptives Market Size (2017-2028)
    10.2 Middle East & Africa Female Contraceptives Market Size by Country (2017-2022)
    10.3 Middle East & Africa Female Contraceptives Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bayer
        11.1.1 Bayer Company Detail
        11.1.2 Bayer Business Overview
        11.1.3 Bayer Female Contraceptives Introduction
        11.1.4 Bayer Revenue in Female Contraceptives Business (2017-2022)
        11.1.5 Bayer Recent Development
    11.2 Mayer Laboratories
        11.2.1 Mayer Laboratories Company Detail
        11.2.2 Mayer Laboratories Business Overview
        11.2.3 Mayer Laboratories Female Contraceptives Introduction
        11.2.4 Mayer Laboratories Revenue in Female Contraceptives Business (2017-2022)
        11.2.5 Mayer Laboratories Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Female Contraceptives Introduction
        11.3.4 Pfizer Revenue in Female Contraceptives Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Mylan
        11.4.1 Mylan Company Detail
        11.4.2 Mylan Business Overview
        11.4.3 Mylan Female Contraceptives Introduction
        11.4.4 Mylan Revenue in Female Contraceptives Business (2017-2022)
        11.4.5 Mylan Recent Development
    11.5 Teva
        11.5.1 Teva Company Detail
        11.5.2 Teva Business Overview
        11.5.3 Teva Female Contraceptives Introduction
        11.5.4 Teva Revenue in Female Contraceptives Business (2017-2022)
        11.5.5 Teva Recent Development
    11.6 Merck
        11.6.1 Merck Company Detail
        11.6.2 Merck Business Overview
        11.6.3 Merck Female Contraceptives Introduction
        11.6.4 Merck Revenue in Female Contraceptives Business (2017-2022)
        11.6.5 Merck Recent Development
    11.7 Johnson & Johnson
        11.7.1 Johnson & Johnson Company Detail
        11.7.2 Johnson & Johnson Business Overview
        11.7.3 Johnson & Johnson Female Contraceptives Introduction
        11.7.4 Johnson & Johnson Revenue in Female Contraceptives Business (2017-2022)
        11.7.5 Johnson & Johnson Recent Development
    11.8 Lupin Pharmaceuticals
        11.8.1 Lupin Pharmaceuticals Company Detail
        11.8.2 Lupin Pharmaceuticals Business Overview
        11.8.3 Lupin Pharmaceuticals Female Contraceptives Introduction
        11.8.4 Lupin Pharmaceuticals Revenue in Female Contraceptives Business (2017-2022)
        11.8.5 Lupin Pharmaceuticals Recent Development
    11.9 Female Health Company
        11.9.1 Female Health Company Company Detail
        11.9.2 Female Health Company Business Overview
        11.9.3 Female Health Company Female Contraceptives Introduction
        11.9.4 Female Health Company Revenue in Female Contraceptives Business (2017-2022)
        11.9.5 Female Health Company Recent Development
    11.10 Fuji Latex
        11.10.1 Fuji Latex Company Detail
        11.10.2 Fuji Latex Business Overview
        11.10.3 Fuji Latex Female Contraceptives Introduction
        11.10.4 Fuji Latex Revenue in Female Contraceptives Business (2017-2022)
        11.10.5 Fuji Latex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Female Contraceptives Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Contraceptive Drugs
    Table 3. Key Players of Contraceptive Devices
    Table 4. Global Female Contraceptives Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Female Contraceptives Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Female Contraceptives Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Female Contraceptives Market Share by Region (2017-2022)
    Table 8. Global Female Contraceptives Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Female Contraceptives Market Share by Region (2023-2028)
    Table 10. Female Contraceptives Market Trends
    Table 11. Female Contraceptives Market Drivers
    Table 12. Female Contraceptives Market Challenges
    Table 13. Female Contraceptives Market Restraints
    Table 14. Global Female Contraceptives Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Female Contraceptives Market Share by Players (2017-2022)
    Table 16. Global Top Female Contraceptives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Contraceptives as of 2021)
    Table 17. Ranking of Global Top Female Contraceptives Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Female Contraceptives Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Female Contraceptives Product Solution and Service
    Table 21. Date of Enter into Female Contraceptives Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Female Contraceptives Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Female Contraceptives Revenue Market Share by Type (2017-2022)
    Table 25. Global Female Contraceptives Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Female Contraceptives Revenue Market Share by Type (2023-2028)
    Table 27. Global Female Contraceptives Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Female Contraceptives Revenue Market Share by Application (2017-2022)
    Table 29. Global Female Contraceptives Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Female Contraceptives Revenue Market Share by Application (2023-2028)
    Table 31. North America Female Contraceptives Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Female Contraceptives Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Female Contraceptives Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Female Contraceptives Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Female Contraceptives Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Female Contraceptives Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Female Contraceptives Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Female Contraceptives Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Female Contraceptives Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Female Contraceptives Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Bayer Company Detail
    Table 42. Bayer Business Overview
    Table 43. Bayer Female Contraceptives Product
    Table 44. Bayer Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 45. Bayer Recent Development
    Table 46. Mayer Laboratories Company Detail
    Table 47. Mayer Laboratories Business Overview
    Table 48. Mayer Laboratories Female Contraceptives Product
    Table 49. Mayer Laboratories Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 50. Mayer Laboratories Recent Development
    Table 51. Pfizer Company Detail
    Table 52. Pfizer Business Overview
    Table 53. Pfizer Female Contraceptives Product
    Table 54. Pfizer Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 55. Pfizer Recent Development
    Table 56. Mylan Company Detail
    Table 57. Mylan Business Overview
    Table 58. Mylan Female Contraceptives Product
    Table 59. Mylan Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 60. Mylan Recent Development
    Table 61. Teva Company Detail
    Table 62. Teva Business Overview
    Table 63. Teva Female Contraceptives Product
    Table 64. Teva Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 65. Teva Recent Development
    Table 66. Merck Company Detail
    Table 67. Merck Business Overview
    Table 68. Merck Female Contraceptives Product
    Table 69. Merck Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 70. Merck Recent Development
    Table 71. Johnson & Johnson Company Detail
    Table 72. Johnson & Johnson Business Overview
    Table 73. Johnson & Johnson Female Contraceptives Product
    Table 74. Johnson & Johnson Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 75. Johnson & Johnson Recent Development
    Table 76. Lupin Pharmaceuticals Company Detail
    Table 77. Lupin Pharmaceuticals Business Overview
    Table 78. Lupin Pharmaceuticals Female Contraceptives Product
    Table 79. Lupin Pharmaceuticals Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 80. Lupin Pharmaceuticals Recent Development
    Table 81. Female Health Company Company Detail
    Table 82. Female Health Company Business Overview
    Table 83. Female Health Company Female Contraceptives Product
    Table 84. Female Health Company Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 85. Female Health Company Recent Development
    Table 86. Fuji Latex Company Detail
    Table 87. Fuji Latex Business Overview
    Table 88. Fuji Latex Female Contraceptives Product
    Table 89. Fuji Latex Revenue in Female Contraceptives Business (2017-2022) & (US$ Million)
    Table 90. Fuji Latex Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Female Contraceptives Market Share by Type: 2021 VS 2028
    Figure 2. Contraceptive Drugs Features
    Figure 3. Contraceptive Devices Features
    Figure 4. Global Female Contraceptives Market Share by Application in 2021 & 2028
    Figure 5. Personal use Case Studies
    Figure 6. Hospital Case Studies
    Figure 7. Female Contraceptives Report Years Considered
    Figure 8. Global Female Contraceptives Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Female Contraceptives Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Female Contraceptives Market Share by Region: 2021 VS 2028
    Figure 11. Global Female Contraceptives Market Share by Players in 2021
    Figure 12. Global Top Female Contraceptives Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Contraceptives as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Female Contraceptives Revenue in 2021
    Figure 14. North America Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Female Contraceptives Market Share by Country (2017-2028)
    Figure 16. United States Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Female Contraceptives Market Share by Country (2017-2028)
    Figure 20. Germany Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Female Contraceptives Market Share by Region (2017-2028)
    Figure 28. China Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Female Contraceptives Market Share by Country (2017-2028)
    Figure 36. Mexico Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Female Contraceptives Market Share by Country (2017-2028)
    Figure 40. Turkey Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Female Contraceptives Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Bayer Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 43. Mayer Laboratories Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 44. Pfizer Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 45. Mylan Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 46. Teva Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 47. Merck Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 48. Johnson & Johnson Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 49. Lupin Pharmaceuticals Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 50. Female Health Company Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 51. Fuji Latex Revenue Growth Rate in Female Contraceptives Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Mayer Laboratories
Pfizer
Mylan
Teva
Merck
Johnson & Johnson
Lupin Pharmaceuticals
Female Health Company
Fuji Latex
Frequently Asked Questions
Female Contraceptives report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Female Contraceptives report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Female Contraceptives report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Fermented Drinks

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More